首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[Epidemiological characteristics of herpes zoster in two cities of Zhejiang Province from 2022 to 2024: an analysis based on a regional health information platform]. 基于区域卫生信息平台的浙江省两市2022-2024年带状疱疹流行病学特征分析
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250722-00699
S Y Wang, Y D Wang, S J Wang, A Tang, Y Wang, L X Qiu, Y X Liang, R B Yu

Objective: To analyze the epidemiological characteristics of herpes zoster (HZ) in Zhoushan and Shaoxing cities of Zhejiang Province from 2022 to 2024. Methods: The HZ data were obtained from the Zhejiang Regional Health Information Platform. Specifically, information was sourced from 42 public hospitals and 149 primary healthcare institutions in Zhoushan and Shaoxing, covering both outpatient and inpatient records (e.g., name, sex, date of birth, ID number, visit date, diagnosis code, admission/discharge dates, and medical expenses). Additionally, vaccination records were matched by ID number from the Zhejiang Immunization Planning Smart Service Information System, including vaccination date, dose, and manufacturer. Permanent resident population data for both cities were collected and stratified by age, sex, and district/county. Based on these data, the epidemiological characteristics of HZ, such as incidence rate, hospitalization rate, and recurrence rate, as well as the occurrence of complications and vaccination, were analyzed. Results: From 2022 to 2024, a total of 45 280 initial HZ cases were identified. The mean age of patients was 57.82 years, with 52.69% being female patients and 95.01% being outpatient cases. Notably, the overall incidence rate of HZ was 3.18‰, showing a significant upward trend (P<0.001). HZ occurred throughout the year without marked seasonality. The incidence rate increased with age (P<0.001). The incidence rate was higher in females than males (3.46‰ vs. 2.91‰, P<0.001) and also higher in Shaoxing than Zhoushan (3.38‰ vs. 1.87‰, P<0.001). Regarding complications, these occurred in 44.51% (20 157/45 280) of patients, with the most common complication being postherpetic neuralgia. The incidence rate of HZ with complications was lower than that without complications (1.41‰ vs. 1.76‰, P<0.001), but both hospitalization (0.14‰ vs. 0.03‰, P<0.001) and recurrence rates (27.43‰ vs. 6.69‰, P<0.001) were higher for cases with complications. Additionally, among individuals aged ≥40 years, the overall HZ vaccination rate was 1.42‰. Conclusion: Herpes zoster imposes a substantial disease burden in Zhejiang Province, while the vaccination rate remains low.

目的:分析浙江省舟山市和绍兴市2022 - 2024年带状疱疹流行病学特征。方法:HZ数据来源于浙江省区域卫生信息平台。具体而言,信息来源于舟山和绍兴市42家公立医院和149家基层卫生保健机构,包括门诊和住院记录(如姓名、性别、出生日期、身份证号码、就诊日期、诊断代码、入院/出院日期、医疗费用等)。此外,疫苗接种记录与浙江省免疫规划智能服务信息系统中的ID号相匹配,包括疫苗接种日期、剂量和制造商。收集了两个城市的常住人口数据,并按年龄、性别和区县进行了分层。在此基础上,分析HZ的流行病学特征,如发病率、住院率、复发率、并发症发生情况、疫苗接种情况等。结果:从2022年到2024年,共发现45 280例HZ首发病例。患者平均年龄57.82岁,女性患者占52.69%,门诊患者占95.01%。值得注意的是,HZ的总发病率为3.18‰,呈明显上升趋势(ppppppp)结论:浙江省带状疱疹的疾病负担较大,但疫苗接种率仍然较低。
{"title":"[Epidemiological characteristics of herpes zoster in two cities of Zhejiang Province from 2022 to 2024: an analysis based on a regional health information platform].","authors":"S Y Wang, Y D Wang, S J Wang, A Tang, Y Wang, L X Qiu, Y X Liang, R B Yu","doi":"10.3760/cma.j.cn112150-20250722-00699","DOIUrl":"10.3760/cma.j.cn112150-20250722-00699","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the epidemiological characteristics of herpes zoster (HZ) in Zhoushan and Shaoxing cities of Zhejiang Province from 2022 to 2024. <b>Methods:</b> The HZ data were obtained from the Zhejiang Regional Health Information Platform. Specifically, information was sourced from 42 public hospitals and 149 primary healthcare institutions in Zhoushan and Shaoxing, covering both outpatient and inpatient records (e.g., name, sex, date of birth, ID number, visit date, diagnosis code, admission/discharge dates, and medical expenses). Additionally, vaccination records were matched by ID number from the Zhejiang Immunization Planning Smart Service Information System, including vaccination date, dose, and manufacturer. Permanent resident population data for both cities were collected and stratified by age, sex, and district/county. Based on these data, the epidemiological characteristics of HZ, such as incidence rate, hospitalization rate, and recurrence rate, as well as the occurrence of complications and vaccination, were analyzed. <b>Results:</b> From 2022 to 2024, a total of 45 280 initial HZ cases were identified. The mean age of patients was 57.82 years, with 52.69% being female patients and 95.01% being outpatient cases. Notably, the overall incidence rate of HZ was 3.18‰, showing a significant upward trend (<i>P</i><0.001). HZ occurred throughout the year without marked seasonality. The incidence rate increased with age (<i>P</i><0.001). The incidence rate was higher in females than males (3.46‰ <i>vs.</i> 2.91‰, <i>P</i><0.001) and also higher in Shaoxing than Zhoushan (3.38‰ <i>vs</i>. 1.87‰, <i>P</i><0.001). Regarding complications, these occurred in 44.51% (20 157/45 280) of patients, with the most common complication being postherpetic neuralgia. The incidence rate of HZ with complications was lower than that without complications (1.41‰ <i>vs</i>. 1.76‰, <i>P</i><0.001), but both hospitalization (0.14‰ <i>vs</i>. 0.03‰, <i>P</i><0.001) and recurrence rates (27.43‰ <i>vs</i>. 6.69‰, <i>P</i><0.001) were higher for cases with complications. Additionally, among individuals aged ≥40 years, the overall HZ vaccination rate was 1.42‰. <b>Conclusion:</b> Herpes zoster imposes a substantial disease burden in Zhejiang Province, while the vaccination rate remains low.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 ","pages":"1877-1882"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145330196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Identification of two novel NF1 mutations and genotype-phenotype analysis in patients with neurofibromatosis type 1]. [两种NF1新突变的鉴定及1型神经纤维瘤病患者的基因型-表型分析]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250701-00616
Z C Li, X Y Chen, Y Yan, X W Wu, R H Liu, Y X Zhang

To investigate the mutations of NF1 and clinical phenotypes in patients with sporadic neurofibromatosis type 1 (NF1). This is aimed to evaluate the efficacy of high-throughput sequencing in diagnosing atypical cases, to expand the mutational spectrum of NF1, and to provide early diagnosis of NF1. Clinical data from 11 sporadic NF1 patients without family history treated at the Fifth Affiliated Hospital of Sun Yat-sen University (2019-2023) were collected. The mutations of NF1 gene were detected using whole-exome sequencing or chip-capture high-throughput sequencing, followed by bioinformatics analysis. Novel mutations were screened against normal population databases to exclude benign polymorphisms, and pathogenicity of the mutations was classified according to ACMG guidelines. The results showed that two novel frameshift mutations were identified: c.7904del (p.Asp2635Valfs*9) and c.5122_5123del (p.Phe1708Hisfs*9). The patient carrying c.7904del exhibited an undocumented phenotype of posterior medullary ischemic degeneration. Among the 11 NF1 patients, the types of mutations included frameshift (4/11), nonsense (3/11), intronic (2/11), splicing (1/11), and start codon variants (1/11). Common phenotypes were cafe-au-lait macules (8/11) and neurofibromas (6/11), yet significant phenotypic heterogeneity existed among patients sharing identical mutations. In conclusion, this study discovered two novel NF1 mutations and an unreported phenotype, expanding both the NF1 mutational spectra and highlights the need for attention to cerebrovascular status in patients carrying NF1 mutations. High-throughput sequencing significantly enhances molecular diagnostic efficacy for atypical NF1, providing a critical basis for clinical NF1 diagnosis.

目的探讨散发性1型神经纤维瘤病(NF1)患者NF1基因突变与临床表型的关系。本研究旨在评估高通量测序对非典型病例的诊断效果,扩大NF1的突变谱,为NF1的早期诊断提供依据。收集2019-2023年中山大学附属第五医院收治的11例无家族史的散发性NF1患者的临床资料。采用全外显子组测序或芯片捕获高通量测序检测NF1基因突变,然后进行生物信息学分析。在正常人群数据库中筛选新突变以排除良性多态性,并根据ACMG指南对突变的致病性进行分类。结果发现两个新的移码突变:c.7904del (p.Asp2635Valfs*9)和c.5122_5123del (p.Phe1708Hisfs*9)。携带c.7904del的患者表现出未记录的后髓缺血性变性表型。在11例NF1患者中,突变类型包括移码(4/11)、无义(3/11)、内含子(2/11)、剪接(1/11)和起始密码子变异(1/11)。常见的表型为咖啡-au-lait斑(8/11)和神经纤维瘤(6/11),但在具有相同突变的患者中存在显著的表型异质性。总之,本研究发现了两种新的NF1突变和一种未报道的表型,扩大了NF1突变谱,并强调了关注携带NF1突变的患者脑血管状态的必要性。高通量测序可显著提高非典型NF1的分子诊断效能,为NF1临床诊断提供重要依据。
{"title":"[Identification of two novel <i>NF1</i> mutations and genotype-phenotype analysis in patients with neurofibromatosis type 1].","authors":"Z C Li, X Y Chen, Y Yan, X W Wu, R H Liu, Y X Zhang","doi":"10.3760/cma.j.cn112150-20250701-00616","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250701-00616","url":null,"abstract":"<p><p>To investigate the mutations of <i>NF1</i> and clinical phenotypes in patients with sporadic neurofibromatosis type 1 (NF1). This is aimed to evaluate the efficacy of high-throughput sequencing in diagnosing atypical cases, to expand the mutational spectrum of <i>NF1</i>, and to provide early diagnosis of NF1. Clinical data from 11 sporadic NF1 patients without family history treated at the Fifth Affiliated Hospital of Sun Yat-sen University (2019-2023) were collected. The mutations of <i>NF1</i> gene were detected using whole-exome sequencing or chip-capture high-throughput sequencing, followed by bioinformatics analysis. Novel mutations were screened against normal population databases to exclude benign polymorphisms, and pathogenicity of the mutations was classified according to ACMG guidelines. The results showed that two novel frameshift mutations were identified: c.7904del (p.Asp2635Valfs*9) and c.5122_5123del (p.Phe1708Hisfs*9). The patient carrying c.7904del exhibited an undocumented phenotype of posterior medullary ischemic degeneration. Among the 11 NF1 patients, the types of mutations included frameshift (4/11), nonsense (3/11), intronic (2/11), splicing (1/11), and start codon variants (1/11). Common phenotypes were cafe-au-lait macules (8/11) and neurofibromas (6/11), yet significant phenotypic heterogeneity existed among patients sharing identical mutations. In conclusion, this study discovered two novel <i>NF1</i> mutations and an unreported phenotype, expanding both the <i>NF1</i> mutational spectra and highlights the need for attention to cerebrovascular status in patients carrying <i>NF1</i> mutations. High-throughput sequencing significantly enhances molecular diagnostic efficacy for atypical NF1, providing a critical basis for clinical NF1 diagnosis.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1938-1945"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Minutes of the vaccine implementation seminar series held in Yan'an City, Shaanxi Province]. [在陕西省延安市举行的疫苗实施系列研讨会纪要]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250814-00791
S B Zhang, X H Pang
{"title":"[Minutes of the vaccine implementation seminar series held in Yan'an City, Shaanxi Province].","authors":"S B Zhang, X H Pang","doi":"10.3760/cma.j.cn112150-20250814-00791","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250814-00791","url":null,"abstract":"","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"2000"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A test-negative study on the protective effectiveness of acellular pertussis vaccine in children aged 2 months to 6 years based on propensity score matching method]. [基于倾向评分匹配法的2个月~ 6岁儿童无细胞百日咳疫苗保护效果试验阴性研究]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250617-00559
Y Zhu, Y Zhou, X H Qi, X J Pan, L L Ding, F X Chen, K Gao, Y Hu, H Q He

Objective: To evaluate the protective effectiveness (VE) of the acellular pertussis vaccine (aPV) against pertussis in children aged 2 months to 6 years. Methods: A test-negative case-control study was conducted among children aged 2 months to 6 years who sought medical care for cough and underwent pertussis nucleic acid testing at sentinel surveillance hospitals in Zhejiang Province in 2024. Cases were defined as those with positive pertussis nucleic acid test results, while controls were test-negative individuals matched 1∶1 based on propensity scores using the caliper matching method. Conditional logistic regression models were used to calculate odds ratios (ORs) and VEs. Results: Among the 658 participants, 31.76% (209 cases) tested positive for pertussis. After propensity score matching, 203 cases and 203 controls were included in the analysis. The VE of 1-2, 3, and 4 doses of aPV against pertussis was 52.46% (95%CI:-39.82%-83.84%), 65.22% (95%CI: 6.86%-87.02%), and 72.21% (95%CI: 34.33%-88.24%), respectively. For pertussis-related hospitalization, the VE of 1-3 and 4 doses was 80.95% (95%CI:31.38%-94.71%) and 86.79% (95%CI: 51.89%-96.37%). The VE for those who completed 4 doses of vaccination and had intervals of less than 2 years, 2 years, 3 years, and 4 years or more after vaccination were 91.15% (95%CI: 67.61%-97.58%), 84.70% (95%CI: 43.71%-95.84%),56.23% (95%CI:-47.58%-87.02%), and 49.92% (95%CI:-83.74%-86.35%), respectively. Conclusion: The VE of aPV against pertussis in children aged 2 months to 6 years increases with the number of doses administered, and it is more effective in preventing hospitalization due to pertussis. The VE declines rapidly over time after the last dose. It is recommended to follow the new pertussis immunization program for timely and full vaccination.

目的:评价无细胞百日咳疫苗(aPV)对2个月~ 6岁儿童百日咳的保护效果。方法:对2024年在浙江省定点监测医院就诊的2月龄~ 6岁因咳嗽就诊并进行百日咳核酸检测的儿童进行检测阴性病例对照研究。病例定义为百日咳核酸检测结果阳性者,对照组为百日咳核酸检测结果阴性者,采用卡尺匹配法按倾向得分匹配1∶1。使用条件逻辑回归模型计算优势比(ORs)和优势比(ve)。结果:658例患者中,百日咳阳性209例,占31.76%。倾向评分匹配后,将203例病例和203例对照纳入分析。1 ~ 2、3、4剂aPV对百日咳的免疫效果分别为52.46% (95%CI:-39.82% ~ 83.84%)、65.22% (95%CI: 6.86% ~ 87.02%)、72.21% (95%CI: 34.33% ~ 88.24%)。在百日咳相关住院治疗中,1-3剂和4剂的VE分别为80.95% (95%CI:31.38% ~ 94.71%)和86.79% (95%CI: 51.89% ~ 96.37%)。完成4剂疫苗接种,接种后间隔时间小于2年、2年、3年、4年及以上者的VE分别为91.15% (95%CI: 67.61% ~ 97.58%)、84.70% (95%CI: 43.71% ~ 95.84%)、56.23% (95%CI:-47.58% ~ 87.02%)、49.92% (95%CI:-83.74% ~ 86.35%)。结论:2个月~ 6岁儿童接种aPV抗百日咳的VE随给药次数的增加而增加,对预防百日咳住院更有效。在最后一次给药后,VE随时间迅速下降。建议按照新的百日咳免疫规划及时、全面接种。
{"title":"[A test-negative study on the protective effectiveness of acellular pertussis vaccine in children aged 2 months to 6 years based on propensity score matching method].","authors":"Y Zhu, Y Zhou, X H Qi, X J Pan, L L Ding, F X Chen, K Gao, Y Hu, H Q He","doi":"10.3760/cma.j.cn112150-20250617-00559","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250617-00559","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate the protective effectiveness (VE) of the acellular pertussis vaccine (aPV) against pertussis in children aged 2 months to 6 years. <b>Methods:</b> A test-negative case-control study was conducted among children aged 2 months to 6 years who sought medical care for cough and underwent pertussis nucleic acid testing at sentinel surveillance hospitals in Zhejiang Province in 2024. Cases were defined as those with positive pertussis nucleic acid test results, while controls were test-negative individuals matched 1∶1 based on propensity scores using the caliper matching method. Conditional logistic regression models were used to calculate odds ratios (<i>ORs</i>) and VEs. <b>Results:</b> Among the 658 participants, 31.76% (209 cases) tested positive for pertussis. After propensity score matching, 203 cases and 203 controls were included in the analysis. The VE of 1-2, 3, and 4 doses of aPV against pertussis was 52.46% (95%<i>CI</i>:-39.82%-83.84%), 65.22% (95%<i>CI</i>: 6.86%-87.02%), and 72.21% (95%<i>CI</i>: 34.33%-88.24%), respectively. For pertussis-related hospitalization, the VE of 1-3 and 4 doses was 80.95% (95%<i>CI</i>:31.38%-94.71%) and 86.79% (95%<i>CI</i>: 51.89%-96.37%). The VE for those who completed 4 doses of vaccination and had intervals of less than 2 years, 2 years, 3 years, and 4 years or more after vaccination were 91.15% (95%<i>CI</i>: 67.61%-97.58%), 84.70% (95%<i>CI</i>: 43.71%-95.84%),56.23% (95%<i>CI</i>:-47.58%-87.02%), and 49.92% (95%<i>CI</i>:-83.74%-86.35%), respectively. <b>Conclusion:</b> The VE of aPV against pertussis in children aged 2 months to 6 years increases with the number of doses administered, and it is more effective in preventing hospitalization due to pertussis. The VE declines rapidly over time after the last dose. It is recommended to follow the new pertussis immunization program for timely and full vaccination.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1834-1839"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of epidemiological characteristics and spatiotemporal clustering of pertussis in Tianjin City from 2010 to 2024]. 2010 - 2024年天津市百日咳流行病学特征及时空聚类分析
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250627-00592
G P Zhang, Y T Guo, Y Liu, T B Fu, Y X Ding

To analyze the epidemiological characteristics and spatiotemporal distribution of pertussis in Tianjin City from 2010 to 2024. Data on pertussis cases reported in Tianjin between January 1, 2010, and December 31, 2024, were extracted from the Infectious Disease Surveillance and Reporting Information System of the China Information System for Disease Control and Prevention. Descriptive epidemiological methods and Joinpoint regression were used to analyze the temporal distribution and incidence trends of pertussis. Spatial autocorrelation analysis and spatial-temporal scanning were employed to characterize the spatial distribution and clustering patterns. The incidence rate of pertussis in Tianjin exhibited an overall upward trend from 2010 to 2024 (AAPC=17.04%, P<0.001), peaking at 11.70 per 100 000 population in 2023. Prior to 2020, the incidence peaked in July and August, whereas from 2023 to 2024, high incidence periods shifted to autumn and winter. The highest average annual incidence rate occurred in the <1-year-old group (165.06 per 100 000), followed by the 5-9-year-old group (20.14 per 100 000). The groups under 1 year old and 1-4 years old showed a trend of first increasing, then decreasing, and subsequently increasing again, with 2018 and 2021 as turning points (P<0.05). Global spatial autocorrelation analysis revealed significant spatial clustering of pertussis cases in Tianjin districts in 2017 (Moran's I=0.19) and 2023 (Moran's I=0.51), with both P<0.05. The spatial-temporal scan analysis identified nine high-incidence clusters, with the primary cluster occurring in 2023, covering Jinnan, Dongli, and Hexi districts (RR=7.37, LLR=568.21, P<0.001). In summary, the incidence of pertussis in Tianjin City has shown an upward trend from 2010 to 2024. The epidemiological characteristics have significantly changed around 2020, with pronounced seasonal and spatial clustering patterns observed in the past two years.

目的分析2010 - 2024年天津市百日咳流行病学特征及时空分布。天津市2010年1月1日至2024年12月31日报告的百日咳病例数据提取自中国疾病预防控制信息系统传染病监测报告信息系统。采用描述流行病学方法和关节点回归分析百日咳的时间分布和发病趋势。采用空间自相关分析和时空扫描表征了空间分布和聚类模式。2010 - 2024年(AAPC=17.04%, PPMoran's I=0.19)和2023年(Moran's I=0.51),天津市百日咳发病率总体呈上升趋势,PRR=7.37, LLR=568.21, P
{"title":"[Analysis of epidemiological characteristics and spatiotemporal clustering of pertussis in Tianjin City from 2010 to 2024].","authors":"G P Zhang, Y T Guo, Y Liu, T B Fu, Y X Ding","doi":"10.3760/cma.j.cn112150-20250627-00592","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250627-00592","url":null,"abstract":"<p><p>To analyze the epidemiological characteristics and spatiotemporal distribution of pertussis in Tianjin City from 2010 to 2024. Data on pertussis cases reported in Tianjin between January 1, 2010, and December 31, 2024, were extracted from the Infectious Disease Surveillance and Reporting Information System of the China Information System for Disease Control and Prevention. Descriptive epidemiological methods and Joinpoint regression were used to analyze the temporal distribution and incidence trends of pertussis. Spatial autocorrelation analysis and spatial-temporal scanning were employed to characterize the spatial distribution and clustering patterns. The incidence rate of pertussis in Tianjin exhibited an overall upward trend from 2010 to 2024 (AAPC=17.04%, <i>P</i><0.001), peaking at 11.70 per 100 000 population in 2023. Prior to 2020, the incidence peaked in July and August, whereas from 2023 to 2024, high incidence periods shifted to autumn and winter. The highest average annual incidence rate occurred in the <1-year-old group (165.06 per 100 000), followed by the 5-9-year-old group (20.14 per 100 000). The groups under 1 year old and 1-4 years old showed a trend of first increasing, then decreasing, and subsequently increasing again, with 2018 and 2021 as turning points (<i>P</i><0.05). Global spatial autocorrelation analysis revealed significant spatial clustering of pertussis cases in Tianjin districts in 2017 (<i>Moran's I</i>=0.19) and 2023 (<i>Moran's I</i>=0.51), with both <i>P</i><0.05. The spatial-temporal scan analysis identified nine high-incidence clusters, with the primary cluster occurring in 2023, covering Jinnan, Dongli, and Hexi districts (<i>RR</i>=7.37, <i>LLR</i>=568.21, <i>P</i><0.001). In summary, the incidence of pertussis in Tianjin City has shown an upward trend from 2010 to 2024. The epidemiological characteristics have significantly changed around 2020, with pronounced seasonal and spatial clustering patterns observed in the past two years.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1867-1872"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Investigation on awareness of the adjusted DTaP immunization schedule and its influencing factors among immunization service personnel in China in 2025]. [2025年中国免疫服务人员对调整后的百白破免疫计划的知晓程度及其影响因素调查]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250610-00531
H W Liu, M S Li, Q Zhang, D Wu, T T Yan, Z J An, H Zheng

Objective: To analyze the awareness of and factors influencing the adjusted national immunization schedule for the diphtheria-tetanus-acellular pertussis (DTaP) vaccine among grassroots immunization service personnel in China. Methods: Based on the snowball sampling method from January to February 2025, immunization service personnel from all provinces of China were selected from the "Tingting Experts Talk" WeChat platform, with concurrent dissemination through the "National Vaccine-Preventable Diseases Communication Group" WeChat group. The questionnaire included basic demographic characteristics and knowledge of the DTaP vaccine immunization policy (13 questions in total). Respondents who answered ≥10 questions correctly were defined as being aware of the policy adjustment. The multivariable logistic regression analysis was performed to identify factors influencing awareness. Results: A total of 8 030 valid questionnaires were collected from 29 provinces, with a valid response rate of 92.91%. The overall awareness accuracy rates among the Centers for Disease Control and Prevention (CDC) personnel and the point of vaccination (POV) staff were 74.1% and 62.5%, respectively. The awareness rate of the core points of policy adjustment among the research subjects exceeded 90%. Among the questions regarding the operational details of policy implementation, the correct rate of answering questions related to the catch-up vaccination principles was relatively low (37.1%-74.0%). The multivariate logistic regression analysis showed that, compared with those with primary titles, CDC personnel with senior titles had higher mastery of the policy adjustment, with an OR (95%CI) value of 2.238 (1.343-3.730). Compared with those engaged in disease surveillance and immunization strategy research, CDC personnel with other work types had lower awareness of the policy adjustment, with an OR (95%CI) value of 0.404 (0.195-0.833). Compared with those in western regions, with primary titles, and without relevant training, POV staff in central regions, eastern regions, with intermediate titles, with senior titles, with one relevant training session, and with ≥2 relevant training sessions had better awareness of the program adjustment, with OR (95%CI) values of 1.214 (1.085-1.358), 1.412 (1.246-1.600), 1.606 (1.446-1.784), 1.737 (1.443-2.091), 2.254 (1.509-3.366), and 2.674 (1.769-3.981), respectively. Compared with those engaged in information registration/recipient notification, POV staff with vaccination services and other work types had lower awareness of the program adjustment, with OR (95%CI) values of 0.713 (0.633-0.803) and 0.508 (0.427-0.604), respectively. Conclusion: Although grassroots immunization service personnel show an insufficient mastery of certain catch-up vaccination knowledge, they demonstrate a good understanding of overall principles and routine immunization sc

目的:分析中国基层免疫服务人员对调整后的白喉-破伤风-无细胞百日咳(DTaP)疫苗国家免疫计划的知晓程度及影响因素。方法:采用滚雪球抽样法,于2025年1 - 2月在“婷婷专家讲坛”微信平台抽取全国各省免疫服务人员,通过“全国疫苗可预防疾病传播群”微信群同步传播。问卷内容包括基本人口统计学特征和对百白破疫苗免疫政策的了解(共13题)。正确回答≥10个问题的被调查者被定义为了解政策调整。采用多变量logistic回归分析确定影响意识的因素。结果:共回收有效问卷8 030份,有效回复率为92.91%。疾病预防控制中心(CDC)人员和疫苗接种点(POV)人员的总体知晓率分别为74.1%和62.5%。研究对象对政策调整核心要点的知晓率超过90%。在政策实施操作细节问题中,与补种原则相关的问题回答正确率相对较低(37.1% ~ 74.0%)。多因素logistic回归分析显示,与初级职称人员相比,高级职称人员对政策调整的掌握程度更高,OR (95%CI)值为2.238(1.343 ~ 3.730)。与从事疾病监测和免疫策略研究的CDC人员相比,其他工作类型的CDC人员对政策调整的知晓程度较低,OR (95%CI)值为0.404(0.195 ~ 0.833)。在西部地区相比,初级职称,没有相关培训,观点的员工在中部地区,东部地区,中级职称,高级职称,与一个相关的训练,和≥2相关训练最好的意识程序调整,或(95% ci)值为1.214(1.085 - -1.358),1.412(1.246 - -1.600),1.606(1.446 - -1.784),1.737(1.443 - -2.091),2.254(1.509 - -3.366),和2.674(1.769 - -3.981)。与从事信息登记/收件人通知工作的工作人员相比,接种服务工作人员和其他工作类型的工作人员对程序调整的知晓程度较低,OR (95%CI)值分别为0.713(0.633-0.803)和0.508(0.427-0.604)。结论:虽然基层免疫服务人员对疫苗接种补习知识掌握不足,但在政策调整后不久,基层免疫服务人员对总体原则和常规免疫计划有了较好的理解,有效保证了新旧免疫策略的有序过渡。
{"title":"[Investigation on awareness of the adjusted DTaP immunization schedule and its influencing factors among immunization service personnel in China in 2025].","authors":"H W Liu, M S Li, Q Zhang, D Wu, T T Yan, Z J An, H Zheng","doi":"10.3760/cma.j.cn112150-20250610-00531","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250610-00531","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the awareness of and factors influencing the adjusted national immunization schedule for the diphtheria-tetanus-acellular pertussis (DTaP) vaccine among grassroots immunization service personnel in China. <b>Methods:</b> Based on the snowball sampling method from January to February 2025, immunization service personnel from all provinces of China were selected from the \"Tingting Experts Talk\" WeChat platform, with concurrent dissemination through the \"National Vaccine-Preventable Diseases Communication Group\" WeChat group. The questionnaire included basic demographic characteristics and knowledge of the DTaP vaccine immunization policy (13 questions in total). Respondents who answered ≥10 questions correctly were defined as being aware of the policy adjustment. The multivariable logistic regression analysis was performed to identify factors influencing awareness. <b>Results:</b> A total of 8 030 valid questionnaires were collected from 29 provinces, with a valid response rate of 92.91%. The overall awareness accuracy rates among the Centers for Disease Control and Prevention (CDC) personnel and the point of vaccination (POV) staff were 74.1% and 62.5%, respectively. The awareness rate of the core points of policy adjustment among the research subjects exceeded 90%. Among the questions regarding the operational details of policy implementation, the correct rate of answering questions related to the catch-up vaccination principles was relatively low (37.1%-74.0%). The multivariate logistic regression analysis showed that, compared with those with primary titles, CDC personnel with senior titles had higher mastery of the policy adjustment, with an <i>OR</i> (95%<i>CI</i>) value of 2.238 (1.343-3.730). Compared with those engaged in disease surveillance and immunization strategy research, CDC personnel with other work types had lower awareness of the policy adjustment, with an <i>OR</i> (95%<i>CI</i>) value of 0.404 (0.195-0.833). Compared with those in western regions, with primary titles, and without relevant training, POV staff in central regions, eastern regions, with intermediate titles, with senior titles, with one relevant training session, and with ≥2 relevant training sessions had better awareness of the program adjustment, with <i>OR</i> (95%<i>CI</i>) values of 1.214 (1.085-1.358), 1.412 (1.246-1.600), 1.606 (1.446-1.784), 1.737 (1.443-2.091), 2.254 (1.509-3.366), and 2.674 (1.769-3.981), respectively. Compared with those engaged in information registration/recipient notification, POV staff with vaccination services and other work types had lower awareness of the program adjustment, with <i>OR</i> (95%<i>CI</i>) values of 0.713 (0.633-0.803) and 0.508 (0.427-0.604), respectively. <b>Conclusion:</b> Although grassroots immunization service personnel show an insufficient mastery of certain catch-up vaccination knowledge, they demonstrate a good understanding of overall principles and routine immunization sc","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1828-1833"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Association between serum vitamin A and E levels and asthma risk in children aged 1-14 years in some areas of Hunan Province]. [湖南省部分地区1-14岁儿童血清维生素A和E水平与哮喘风险的关系]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250723-00710
B C Wu, J H Zhu, L Xiao, Q Hu, L H Liu, S T Xiang

To analyze the relationship between serum vitamin A and E levels and asthma risk in children aged 1-14 years. Based on a multi-center case-control study design, general information and vitamin A and E test data were collected from asthmatic children in the respiratory outpatient departments of four medical institutions in Hunan Province and control children undergoing health check-ups in the child healthcare departments during the same period from July 2017 to October 2019.After 1∶1 matching age and gender using propensity scores, a total of 2 454 research subjects were included. 1 730 boys and 724 girls, with an age range of 1-14 years, a median age of 3 years and a mean age of (3.58±2.83) years. The levels of vitamin A and E in the asthma group and the control group were compared. Binary Logistic regression was used to analyze the association between vitamin levels and asthma, and stratified analysis by age and gender was conducted. The results showed that a total of 3 447 research subjects were initially included in this study, and 2 454 research subjects were included after propensity scores matching (PSM). After matching, there was no statistically significant difference in age and gender between the two groups (χ²=0.00,P>0.05), and the standardized mean difference (SMD) values were all less than 10%.The levels of vitamin A and E in the asthma group were significantly lower than those in the control group [(0.32±0.09)mg/L vs.(0.34±0.08)mg/L,t=4.94,P<0.001;(8.90±2.47)mg/L vs.(9.19±2.58) mg/L,t=2.79,P=0.005]. Compared to the normal vitamin A group, the high-risk subclinical deficiency group (OR=1.53, 95%CI: 1.28-1.83) and the subclinical/clinical deficiency group (OR=2.68, 95%CI: 1.81-3.97) were significantly positively associated with asthma risk. Compared to the normal vitamin E group, the vitamin E insufficient group was significantly associated with increased asthma risk (OR=1.28, 95%CI: 1.03-1.57). Subgroup analysis revealed that subclinical/clinical vitamin A deficiency was significantly associated with increased asthma risk across all age groups and both genders (all P<0.05), whereas vitamin E insufficiency was only associated with higher asthma risk in the 1-3 age group and among girls (P<0.05).In conclusion, subclinical or clinical deficiency of vitamin A may significantly increase the risk of asthma. Vitamin E deficiency is mainly associated with an increased risk of asthma in younger age groups (1-<3 age group) and girls.

分析1 ~ 14岁儿童血清维生素A、E水平与哮喘发病的关系。采用多中心病例对照研究设计,收集2017年7月至2019年10月湖南省4家医疗机构呼吸门诊哮喘患儿的一般信息和维生素a、E检测数据,以及同期在儿童保健科体检的对照患儿。采用倾向评分法对年龄和性别进行1∶1匹配,共纳入2 454名研究对象。男1 730例,女724例,年龄1 ~ 14岁,中位年龄3岁,平均年龄(3.58±2.83)岁。比较哮喘组和对照组的维生素A、E水平。采用二元Logistic回归分析维生素水平与哮喘的相关性,并按年龄和性别进行分层分析。结果表明,本研究共纳入3 447名研究对象,经倾向得分匹配(PSM)后纳入2 454名研究对象。配对后,两组患者年龄、性别差异无统计学意义(χ²=0.00,P < 0.05),标准化平均差异(SMD)值均小于10%。哮喘组患者维生素A、E水平显著低于对照组[(0.32±0.09)mg/L vs(0.34±0.08)mg/L,t=4.94; Pvs(9.19±2.58)mg/L,t=2.79,P=0.005]。与正常维生素A组相比,高危亚临床缺乏组(OR=1.53, 95%CI: 1.28 ~ 1.83)和亚临床/临床缺乏组(OR=2.68, 95%CI: 1.81 ~ 3.97)与哮喘风险显著正相关。与正常维生素E组相比,维生素E不足组与哮喘风险增加显著相关(OR=1.28, 95%CI: 1.03-1.57)。亚组分析显示,在所有年龄组和性别中,亚临床/临床维生素A缺乏症与哮喘风险增加显著相关(均PP0.05)。总之,亚临床或临床缺乏维生素A可显著增加哮喘的风险。维生素E缺乏主要与年轻年龄组哮喘风险增加有关(1-
{"title":"[Association between serum vitamin A and E levels and asthma risk in children aged 1-14 years in some areas of Hunan Province].","authors":"B C Wu, J H Zhu, L Xiao, Q Hu, L H Liu, S T Xiang","doi":"10.3760/cma.j.cn112150-20250723-00710","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250723-00710","url":null,"abstract":"<p><p>To analyze the relationship between serum vitamin A and E levels and asthma risk in children aged 1-14 years. Based on a multi-center case-control study design, general information and vitamin A and E test data were collected from asthmatic children in the respiratory outpatient departments of four medical institutions in Hunan Province and control children undergoing health check-ups in the child healthcare departments during the same period from July 2017 to October 2019.After 1∶1 matching age and gender using propensity scores, a total of 2 454 research subjects were included. 1 730 boys and 724 girls, with an age range of 1-14 years, a median age of 3 years and a mean age of (3.58±2.83) years. The levels of vitamin A and E in the asthma group and the control group were compared. Binary Logistic regression was used to analyze the association between vitamin levels and asthma, and stratified analysis by age and gender was conducted. The results showed that a total of 3 447 research subjects were initially included in this study, and 2 454 research subjects were included after propensity scores matching (PSM). After matching, there was no statistically significant difference in age and gender between the two groups (<i>χ</i>²=0.00<b>,</b><i>P</i>>0.05), and the standardized mean difference (SMD) values were all less than 10%.The levels of vitamin A and E in the asthma group were significantly lower than those in the control group [(0.32±0.09)mg/L <i>vs.</i>(0.34±0.08)mg/L,<i>t</i>=4.94<b>,</b><i>P</i><0.001;(8.90±2.47)mg/L <i>vs.</i>(9.19±2.58) mg/L,<i>t</i>=2.79<b>,</b><i>P</i>=0.005]. Compared to the normal vitamin A group, the high-risk subclinical deficiency group (<i>OR</i>=1.53, 95%<i>CI</i>: 1.28-1.83) and the subclinical/clinical deficiency group (<i>OR</i>=2.68, 95%<i>CI</i>: 1.81-3.97) were significantly positively associated with asthma risk. Compared to the normal vitamin E group, the vitamin E insufficient group was significantly associated with increased asthma risk (<i>OR</i>=1.28, 95%<i>CI</i>: 1.03-1.57). Subgroup analysis revealed that subclinical/clinical vitamin A deficiency was significantly associated with increased asthma risk across all age groups and both genders (all <i>P</i><0.05), whereas vitamin E insufficiency was only associated with higher asthma risk in the 1-3 age group and among girls (<i>P<</i>0.05).In conclusion, subclinical or clinical deficiency of vitamin A may significantly increase the risk of asthma. Vitamin E deficiency is mainly associated with an increased risk of asthma in younger age groups (1-<3 age group) and girls.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1932-1937"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the prevalence and clinical characteristics of pertussis in children with different cough durations]. 不同咳嗽持续时间儿童百日咳患病率及临床特点分析
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250628-00601
W T Li, L Li, F L Wu, Y L Jiao, X W Zhang, J Li, R Z Zhang, L Wang, X Ma

Objective: To analyze the prevalence and clinical characteristics of pertussis in children with different cough durations. Methods: From January 2021 to October 2022, information on children aged 0-18 years who visited eight hospitals in Shandong Province due to cough was enrolled. Pertussis serological antibody testing and/or nucleic acid testing were performed. The prevalence and clinical characteristics of pertussis were compared among the acute cough group, protracted cough group, and chronic cough group using the χ² test or Fisher's exact test. Results: A total of 1 565 children with cough were included in the study, of which 348 (22.24%) were laboratory-confirmed pertussis. There was a significant difference in the laboratory-confirmed rate of pertussis among different cough groups (χ²=83.424, P<0.001). The confirmation rate of pertussis in the protracted cough group (42.21%) was significantly higher than that in the acute cough group (16.49%, P<0.05) and chronic cough group (19.50%, P<0.05). In each cough group, the age of children was significantly associated with the confirmed rate of pertussis, and the confirmed rate was relatively high in children aged 3 months to <2 years. Pertussis vaccination was significantly associated with the confirmed rate in all groups, and the confirmed rate was higher in unvaccinated children. Among laboratory-confirmed pertussis cases, the incidence of typical symptoms such as paroxysmal cough, whoop, and post-tussive emesis or sleep disturbance was significantly higher than that in the non-confirmed cases. In the protracted and chronic cough groups, the proportion of non-confirmed cases complicated with asthma/cough variant asthma (CVA) was significantly higher than that in pertussis-confirmed cases. Conclusion: There are differences in the confirmation rate of pertussis among children with different cough durations. The confirmation rate is significantly associated with age, vaccination status, and clinical symptoms. Enhancing clinical vigilance against pertussis, conducting early diagnosis, and getting timely and standardized vaccination are crucial for effectively controlling pertussis and preventing outbreaks.

目的:分析不同咳嗽持续时间儿童百日咳的患病率及临床特点。方法:收集2021年1月至2022年10月山东省8家医院因咳嗽就诊的0 ~ 18岁儿童资料。进行百日咳血清学抗体和/或核酸检测。采用χ 2检验或Fisher精确检验比较急性咳嗽组、持续性咳嗽组和慢性咳嗽组百日咳的患病率和临床特征。结果:共纳入1565例咳嗽患儿,其中实验室确诊百日咳348例(22.24%)。不同咳嗽组百日咳实验室确诊率差异有统计学意义(χ²=83.424,ppp)。结论:不同咳嗽持续时间儿童百日咳确诊率存在差异。确诊率与年龄、疫苗接种状况和临床症状显著相关。提高临床对百日咳的警惕性,及早诊断,及时规范接种疫苗,是有效控制百日咳,预防百日咳爆发的关键。
{"title":"[Analysis of the prevalence and clinical characteristics of pertussis in children with different cough durations].","authors":"W T Li, L Li, F L Wu, Y L Jiao, X W Zhang, J Li, R Z Zhang, L Wang, X Ma","doi":"10.3760/cma.j.cn112150-20250628-00601","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250628-00601","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the prevalence and clinical characteristics of pertussis in children with different cough durations. <b>Methods:</b> From January 2021 to October 2022, information on children aged 0-18 years who visited eight hospitals in Shandong Province due to cough was enrolled. Pertussis serological antibody testing and/or nucleic acid testing were performed. The prevalence and clinical characteristics of pertussis were compared among the acute cough group, protracted cough group, and chronic cough group using the <i>χ²</i> test or Fisher's exact test. <b>Results:</b> A total of 1 565 children with cough were included in the study, of which 348 (22.24%) were laboratory-confirmed pertussis. There was a significant difference in the laboratory-confirmed rate of pertussis among different cough groups (<i>χ²</i>=83.424, <i>P</i><0.001). The confirmation rate of pertussis in the protracted cough group (42.21%) was significantly higher than that in the acute cough group (16.49%, <i>P</i><0.05) and chronic cough group (19.50%, <i>P</i><0.05). In each cough group, the age of children was significantly associated with the confirmed rate of pertussis, and the confirmed rate was relatively high in children aged 3 months to <2 years. Pertussis vaccination was significantly associated with the confirmed rate in all groups, and the confirmed rate was higher in unvaccinated children. Among laboratory-confirmed pertussis cases, the incidence of typical symptoms such as paroxysmal cough, whoop, and post-tussive emesis or sleep disturbance was significantly higher than that in the non-confirmed cases. In the protracted and chronic cough groups, the proportion of non-confirmed cases complicated with asthma/cough variant asthma (CVA) was significantly higher than that in pertussis-confirmed cases. <b>Conclusion:</b> There are differences in the confirmation rate of pertussis among children with different cough durations. The confirmation rate is significantly associated with age, vaccination status, and clinical symptoms. Enhancing clinical vigilance against pertussis, conducting early diagnosis, and getting timely and standardized vaccination are crucial for effectively controlling pertussis and preventing outbreaks.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1855-1860"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pathogenomic surveillance of Bordetella pertussis clinical isolates in Liaocheng City, Shandong Province in 2024]. [2024年山东省聊城市百日咳博德氏菌临床分离株病理学监测]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20250707-00632
J L Jia, J Che, L L Zheng, J Z Zhang, H Liu, R Yang, G Q Li, X S Lu, H Yuan

Objective: To analyze the molecular characteristics of prevalent Bordetella pertussis (Bp) isolates in Liaocheng City, Shandong Province in 2024. Methods: From March to August 2024, oropharyngeal swabs were collected from suspected pertussis cases at Liaocheng People's Hospital in Shandong Province for Bp isolation. A total of 99 Bp isolates were obtained. Whole-genome sequencing was performed on all isolates, followed by Multilocus Sequence Typing (MLST), vaccine antigen-related gene typing (including ptxP, ptxA, ptxB, ptxC, ptxD, ptxE, fhaB, fim2, fim3, and prn), 23S rRNA gene typing, and phylogenetic analysis. To capture the differences between Bp isolates and vaccine strains in Liaocheng City, the international vaccine strain Tohama I and the Chinese vaccine strain CS were included in the analysis. Antimicrobial resistance testing against 11 agents was performed on 52 isolates. Results: The throat swabs of 99 Bp isolates were collected from patients aged 44 days to 42 years, and the median age of the patients was 7 (5, 8) years. All isolates ptxP were ptxP3 type. 74 isolates (74.75%) carried the prn150, while 21 isolates (21.21%) were prn-deficient. The predominant antigenic profile was ptxP3/ptxA1/ptxB1/ptxC4/ptxD1/ptxE4/fhaB1/fim2-1/fim3-1/prn150, found in 72 isolates (72.73%). All 99 isolates carried the A2047G mutation in the 23S rRNA gene. Antimicrobial susceptibility testing showed that the MICs of macrolides and clindamycin for all 52 Bp isolates were all >256 mg/L. However, the isolates showed low MIC for seven other antimicrobials tested, including trimethoprim-sulfamethoxazole, amoxicillin, and levofloxacin. MLST typing revealed that 94 isolates (94.95%) were identified as ST-2, while 5 isolates (5.05%) belonged to a novel sequence type (ST-118). Phylogenetic analysis demonstrated that all 99 Bp isolates were highly homologous but clustered in evolutionary branches distinct from vaccine strains. Conclusion: In 2024, Bordetella pertussis isolates in Liaocheng City exhibit distinct clonal epidemic characteristics, with the predominant antigenic genotype being ptxP3/ptxA1/ptxB1/ptxC4/ptxD1/ptxE4/fhaB1/fim2-1/fim3-1/prn150. All isolates are resistant to macrolide antibiotics.

目的:分析2024年山东省聊城市流行百日咳杆菌(Bp)分离株的分子特征。方法:于2024年3月至8月在山东省聊城市人民医院采集疑似百日咳患者口咽拭子进行Bp分离。共分离得到99个Bp。对所有分离株进行全基因组测序,然后进行多位点序列分型(MLST)、疫苗抗原相关基因分型(包括ptxP、ptxA、ptxB、ptxC、ptxD、ptxE、fhaB、fim2、fim3和prn)、23S rRNA基因分型和系统发育分析。为了解聊城市Bp分离株与疫苗株之间的差异,将国际疫苗株Tohama I和中国疫苗株CS纳入分析。对52株分离株进行了11种药物耐药试验。结果:从44天~ 42岁的患者中采集到99株Bp分离株咽拭子,患者年龄中位数为7(5,8)岁。所有分离株ptxP均为ptxP3型。74株(74.75%)携带prn150, 21株(21.21%)prn缺失。主要抗原谱为ptxP3/ptxA1/ptxB1/ptxC4/ptxD1/ptxE4/fhaB1/fim2-1/fim3-1/prn150,共72株(72.73%)。所有99株菌株均携带23S rRNA基因A2047G突变。52株Bp的大环内酯类药物和克林霉素的mic均为bb0 ~ 256mg /L。然而,这些分离株对其他7种抗菌素的MIC较低,包括甲氧苄啶-磺胺甲恶唑、阿莫西林和左氧氟沙星。MLST分型结果显示,94株(94.95%)为ST-2型,5株(5.05%)为新序列型(ST-118)。系统发育分析表明,所有99 Bp的分离株高度同源,但聚集在不同于疫苗株的进化分支上。结论:2024年聊城市百日咳杆菌分离株具有明显的克隆流行特征,主要抗原基因型为ptxP3/ptxA1/ptxB1/ptxC4/ptxD1/ptxE4/fhaB1/fim2-1/fim3-1/prn150。所有分离株均对大环内酯类抗生素耐药。
{"title":"[Pathogenomic surveillance of <i>Bordetella pertussis</i> clinical isolates in Liaocheng City, Shandong Province in 2024].","authors":"J L Jia, J Che, L L Zheng, J Z Zhang, H Liu, R Yang, G Q Li, X S Lu, H Yuan","doi":"10.3760/cma.j.cn112150-20250707-00632","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20250707-00632","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the molecular characteristics of prevalent <i>Bordetella pertussis</i> (Bp) isolates in Liaocheng City, Shandong Province in 2024. <b>Methods:</b> From March to August 2024, oropharyngeal swabs were collected from suspected pertussis cases at Liaocheng People's Hospital in Shandong Province for Bp isolation. A total of 99 Bp isolates were obtained. Whole-genome sequencing was performed on all isolates, followed by Multilocus Sequence Typing (MLST), vaccine antigen-related gene typing (including <i>ptxP</i>, <i>ptxA</i>, <i>ptxB</i>, <i>ptxC</i>, <i>ptxD</i>, <i>ptxE</i>, <i>fhaB</i>, <i>fim2</i>, <i>fim3</i>, and <i>prn</i>), 23S rRNA gene typing, and phylogenetic analysis. To capture the differences between Bp isolates and vaccine strains in Liaocheng City, the international vaccine strain Tohama I and the Chinese vaccine strain CS were included in the analysis. Antimicrobial resistance testing against 11 agents was performed on 52 isolates. <b>Results:</b> The throat swabs of 99 Bp isolates were collected from patients aged 44 days to 42 years, and the median age of the patients was 7 (5, 8) years. All isolates <i>ptxP</i> were <i>ptxP3</i> type. 74 isolates (74.75%) carried the <i>prn150</i>, while 21 isolates (21.21%) were <i>prn-deficient</i>. The predominant antigenic profile was <i>ptxP3</i>/<i>ptxA1</i>/<i>ptxB1</i>/<i>ptxC4</i>/<i>ptxD1</i>/<i>ptxE4</i>/<i>fhaB1</i>/<i>fim2-1</i>/<i>fim3-1</i>/<i>prn150</i>, found in 72 isolates (72.73%). All 99 isolates carried the A2047G mutation in the 23S rRNA gene. Antimicrobial susceptibility testing showed that the MICs of macrolides and clindamycin for all 52 Bp isolates were all >256 mg/L. However, the isolates showed low MIC for seven other antimicrobials tested, including trimethoprim-sulfamethoxazole, amoxicillin, and levofloxacin. MLST typing revealed that 94 isolates (94.95%) were identified as ST-2, while 5 isolates (5.05%) belonged to a novel sequence type (ST-118). Phylogenetic analysis demonstrated that all 99 Bp isolates were highly homologous but clustered in evolutionary branches distinct from vaccine strains. <b>Conclusion:</b> In 2024, <i>Bordetella pertussis</i> isolates in Liaocheng City exhibit distinct clonal epidemic characteristics, with the predominant antigenic genotype being <i>ptxP3</i>/<i>ptxA1</i>/<i>ptxB1</i>/<i>ptxC4</i>/<i>ptxD1</i>/<i>ptxE4</i>/<i>fhaB1</i>/<i>fim2-1</i>/<i>fim3-1</i>/<i>prn150</i>. All isolates are resistant to macrolide antibiotics.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1848-1854"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of the association between moderate-to-vigorous-physical activity and obesity, poor sleep quality and multimorbidity in 7- to 8-year-old children in Shanghai City]. [上海市7- 8岁儿童中高强度运动与肥胖、睡眠质量差和多病的关系分析]。
Q3 Medicine Pub Date : 2025-11-06 DOI: 10.3760/cma.j.cn112150-20241210-00992
Q Yan, W L Chen, L T Chu, L J Sun, X Y Lian, J H Guo, C Y Luo, J Li

Objective: To analyze the association between moderate-to-vigorous-physical activity (MVPA) and obesity, poor sleep quality, as well as multimorbidity in 7- to 8-year-old children in Shanghai City. Methods: From September to November 2023, a cluster sampling method was used to select second-grade students from four primary schools in Jinshan District, Shanghai. Three-axis acceleration motion sensors (GT3X+, Acti-graph) were used to monitor daily physical activity for seven consecutive days. A multivariate logistic regression model was used to analyze the association between MVPA duration characteristics and obesity, poor sleep quality and multimorbidity in school-age children. Results: Of the 937 study participants, 512 (54.64%) were boys and 425 (45.36%) were girls. Among them, 89 (9.50%) were obese and 782 (83.46%) had poor sleep quality. A total of 77 cases (8.22%) were affected by obesity and poor sleep quality. The average daily MVPA time was (45.97±15.87) minutes, and the MVPA attainment rate was 17.18%. The multivariate logistic regression model analysis showed that, after adjusting for covariates, the daily average MVPA time was negatively associated with the risk of obesity (OR=0.982, 95%CI: 0.968-0.997), as well as multimorbidity (OR=0.981, 95%CI: 0.965-0.997). The risk of obesity, poor sleep quality and multimorbidity in <1 d was 2.228 (OR=2.228, 95%CI: 1.398-3.549), 1.702 (OR=1.702, 95%CI: 1.141-2.540) and 2.150 (OR=2.150, 95%CI: 1.310-3.528) times higher than that in ≥1 d. Conclusion: Obesity, poor sleep quality and multimorbidity of school-age children are closely related to the level of moderate-to-vigorous physical activity.

目的:分析上海市7 ~ 8岁儿童中高强度体力活动(MVPA)与肥胖、睡眠质量差及多病的关系。方法:采用整群抽样方法,于2023年9 - 11月对上海市金山区4所小学二年级学生进行抽样调查。使用三轴加速度运动传感器(GT3X+, actig -graph)连续7天监测日常身体活动。采用多元logistic回归模型分析学龄期儿童MVPA持续时间特征与肥胖、睡眠质量差和多病的关系。结果:937名研究参与者中,男孩512名(54.64%),女孩425名(45.36%)。其中肥胖89人(9.50%),睡眠质量差782人(83.46%)。77例(8.22%)受肥胖和睡眠质量差影响。平均每日MVPA时间为(45.97±15.87)min, MVPA达标率为17.18%。多因素logistic回归模型分析显示,调整协变量后,每日平均MVPA时间与肥胖风险(OR=0.982, 95%CI: 0.968 ~ 0.997)和多病风险(OR=0.981, 95%CI: 0.965 ~ 0.997)呈负相关。学龄期儿童肥胖、睡眠质量差、多病发生率分别为≥1 d时的OR=2.228, 95%CI: 1.398-3.549, 1.702 (OR=1.702, 95%CI: 1.141-2.540)和2.150 (OR=2.150, 95%CI: 1.310-3.528)倍。结论:学龄期儿童肥胖、睡眠质量差、多病发生率与中高强度体育活动水平密切相关。
{"title":"[Analysis of the association between moderate-to-vigorous-physical activity and obesity, poor sleep quality and multimorbidity in 7- to 8-year-old children in Shanghai City].","authors":"Q Yan, W L Chen, L T Chu, L J Sun, X Y Lian, J H Guo, C Y Luo, J Li","doi":"10.3760/cma.j.cn112150-20241210-00992","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20241210-00992","url":null,"abstract":"<p><p><b>Objective:</b> To analyze the association between moderate-to-vigorous-physical activity (MVPA) and obesity, poor sleep quality, as well as multimorbidity in 7- to 8-year-old children in Shanghai City. <b>Methods:</b> From September to November 2023, a cluster sampling method was used to select second-grade students from four primary schools in Jinshan District, Shanghai. Three-axis acceleration motion sensors (GT3X+, Acti-graph) were used to monitor daily physical activity for seven consecutive days. A multivariate logistic regression model was used to analyze the association between MVPA duration characteristics and obesity, poor sleep quality and multimorbidity in school-age children. <b>Results:</b> Of the 937 study participants, 512 (54.64%) were boys and 425 (45.36%) were girls. Among them, 89 (9.50%) were obese and 782 (83.46%) had poor sleep quality. A total of 77 cases (8.22%) were affected by obesity and poor sleep quality. The average daily MVPA time was (45.97±15.87) minutes, and the MVPA attainment rate was 17.18%. The multivariate logistic regression model analysis showed that, after adjusting for covariates, the daily average MVPA time was negatively associated with the risk of obesity (<i>OR</i>=0.982, 95%<i>CI</i>: 0.968-0.997), as well as multimorbidity (<i>OR</i>=0.981, 95%<i>CI</i>: 0.965-0.997). The risk of obesity, poor sleep quality and multimorbidity in <1 d was 2.228 (<i>OR</i>=2.228, 95%<i>CI</i>: 1.398-3.549), 1.702 (<i>OR</i>=1.702, 95%<i>CI</i>: 1.141-2.540) and 2.150 (<i>OR</i>=2.150, 95%<i>CI</i>: 1.310-3.528) times higher than that in ≥1 d. <b>Conclusion:</b> Obesity, poor sleep quality and multimorbidity of school-age children are closely related to the level of moderate-to-vigorous physical activity.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":"59 11","pages":"1924-1931"},"PeriodicalIF":0.0,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145597740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1